These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 15466367

  • 1. Chylomicron remnant uptake in the livers of mice expressing human apolipoproteins E3, E2 (Arg158-->Cys), and E3-Leiden.
    Lee SJ, Grosskopf I, Choi SY, Cooper AD.
    J Lipid Res; 2004 Dec; 45(12):2199-210. PubMed ID: 15466367
    [Abstract] [Full Text] [Related]

  • 2. Hyperlipidemia of ApoE2(Arg(158)-Cys) and ApoE3-Leiden transgenic mice is modulated predominantly by LDL receptor expression.
    van Dijk KW, van Vlijmen BJ, de Winther MP, van 't Hof B, van der Zee A, van der Boom H, Havekes LM, Hofker MH.
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2945-51. PubMed ID: 10591674
    [Abstract] [Full Text] [Related]

  • 3. Reversal of hypercholesterolemia in apolipoprotein E2 and apolipoprotein E3-Leiden transgenic mice by adenovirus-mediated gene transfer of the VLDL receptor.
    van Dijk KW, van Vlijmen BJ, van der Zee A, van't Hof B, van der Boom H, Kobayashi K, Chan L, Havekes LM, Hofker MH.
    Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):7-12. PubMed ID: 9445249
    [Abstract] [Full Text] [Related]

  • 4. Effect of macrophage-derived mouse ApoE, human ApoE3-Leiden, and human ApoE2 (Arg158-->Cys) on cholesterol levels and atherosclerosis in ApoE-deficient mice.
    Van Eck M, Herijgers N, Van Dijk KW, Havekes LM, Hofker MH, Groot PH, Van Berkel TJ.
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):119-27. PubMed ID: 10634808
    [Abstract] [Full Text] [Related]

  • 5. Rapid initial removal of chylomicron remnants by the mouse liver does not require hepatically localized apolipoprotein E.
    Yu KC, Jiang Y, Chen W, Cooper AD.
    J Lipid Res; 2000 Nov; 41(11):1715-27. PubMed ID: 11060341
    [Abstract] [Full Text] [Related]

  • 6. Relative roles of LDLr and LRP in the metabolism of chylomicron remnants in genetically manipulated mice.
    Martins IJ, Hone E, Chi C, Seydel U, Martins RN, Redgrave TG.
    J Lipid Res; 2000 Feb; 41(2):205-13. PubMed ID: 10681404
    [Abstract] [Full Text] [Related]

  • 7. Impaired secretion of apolipoprotein E2 from macrophages.
    Fan D, Qiu S, Overton CD, Yancey PG, Swift LL, Jerome WG, Linton MF, Fazio S.
    J Biol Chem; 2007 May 04; 282(18):13746-53. PubMed ID: 17341585
    [Abstract] [Full Text] [Related]

  • 8. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia.
    Ji ZS, Fazio S, Mahley RW.
    J Biol Chem; 1994 May 06; 269(18):13421-8. PubMed ID: 8175773
    [Abstract] [Full Text] [Related]

  • 9. Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor.
    Herz J, Qiu SQ, Oesterle A, DeSilva HV, Shafi S, Havel RJ.
    Proc Natl Acad Sci U S A; 1995 May 09; 92(10):4611-5. PubMed ID: 7753850
    [Abstract] [Full Text] [Related]

  • 10. The carboxyl terminus in apolipoprotein E2 and the seven amino acid repeat in apolipoprotein E-Leiden: role in receptor-binding activity.
    Dong LM, Innerarity TL, Arnold KS, Newhouse YM, Weisgraber KH.
    J Lipid Res; 1998 Jun 09; 39(6):1173-80. PubMed ID: 9643348
    [Abstract] [Full Text] [Related]

  • 11. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans.
    Ji ZS, Fazio S, Lee YL, Mahley RW.
    J Biol Chem; 1994 Jan 28; 269(4):2764-72. PubMed ID: 8300609
    [Abstract] [Full Text] [Related]

  • 12. Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner.
    Johnson LA, Olsen RH, Merkens LS, DeBarber A, Steiner RD, Sullivan PM, Maeda N, Raber J.
    Neurobiol Dis; 2014 Apr 28; 64():150-62. PubMed ID: 24412220
    [Abstract] [Full Text] [Related]

  • 13. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
    Kypreos KE, Li X, van Dijk KW, Havekes LM, Zannis VI.
    Biochemistry; 2003 Aug 26; 42(33):9841-53. PubMed ID: 12924933
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intracellular localization and metabolism of chylomicron remnants in the livers of low density lipoprotein receptor-deficient mice and apoE-deficient mice. Evidence for slow metabolism via an alternative apoE-dependent pathway.
    Mortimer BC, Beveridge DJ, Martins IJ, Redgrave TG.
    J Biol Chem; 1995 Dec 01; 270(48):28767-76. PubMed ID: 7499399
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.